INTRODUCTION:Single-incision devices for the treatment of stress urinary incontinence (SUI) have been introduced in the last few years. We report a comparison between Obturator Tension-free vaginal tape (TVT-O) and Contasure-Needleless (C-NDL). METHODS:One hundred and fifty-eight women with primary SUI were scheduled to receive TVT-O or C-NDL and follow-up during the first year. Epidemiological information, complications, blood loss, and pain level were recorded. We also analyze stress test and quality of life. RESULTS: Sixty-three (87.5%) C-NDL presented a negative stress test, compared with 54 (90%) of TVT-O (p value 0.015 for non-inferiority test). Sandvik Severity Index was 0 in 75.4% in the C-NDL group and 87.3% in the TVT-O (p < 0.015). Complication rate and degree of satisfaction were similar in both groups. Statistically, there were differences (p = 0.012) in postoperative pain in the TVT-O group. CONCLUSIONS: C-NDL provides similar outcomes as TVT-O after 1-year follow-up. It is necessary that long-term data confirm our results.
RCT Entities:
INTRODUCTION: Single-incision devices for the treatment of stress urinary incontinence (SUI) have been introduced in the last few years. We report a comparison between Obturator Tension-free vaginal tape (TVT-O) and Contasure-Needleless (C-NDL). METHODS: One hundred and fifty-eight women with primary SUI were scheduled to receive TVT-O or C-NDL and follow-up during the first year. Epidemiological information, complications, blood loss, and pain level were recorded. We also analyze stress test and quality of life. RESULTS: Sixty-three (87.5%) C-NDL presented a negative stress test, compared with 54 (90%) of TVT-O (p value 0.015 for non-inferiority test). Sandvik Severity Index was 0 in 75.4% in the C-NDL group and 87.3% in the TVT-O (p < 0.015). Complication rate and degree of satisfaction were similar in both groups. Statistically, there were differences (p = 0.012) in postoperative pain in the TVT-O group. CONCLUSIONS:C-NDL provides similar outcomes as TVT-O after 1-year follow-up. It is necessary that long-term data confirm our results.
Authors: Ehab El-Barky; Ali El-Shazly; Osama Abdul El-Wahab; Elijah O Kehinde; Adel Al-Hunayan; Khaleel A Al-Awadi Journal: Int Urol Nephrol Date: 2005 Impact factor: 2.370
Authors: Irene Mora Hervás; Lluís Amat Tardiu; Eva Martínez Franco; Josep María Lailla Vicens Journal: Arch Esp Urol Date: 2007-11 Impact factor: 0.436
Authors: Matthew D Barber; Steven Kleeman; Mickey M Karram; Marie Fidela R Paraiso; Mark D Walters; Sandip Vasavada; Mark Ellerkmann Journal: Obstet Gynecol Date: 2008-03 Impact factor: 7.661
Authors: G Ghoniem; E Stanford; K Kenton; C Achtari; R Goldberg; T Mascarenhas; M Parekh; K Tamussino; S Tosson; G Lose; E Petri Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2007-11-17
Authors: Mohammed S ElSheemy; Hesham Fathy; Hussein A Hussein; Eman A Hussein; Sarah Mohamed Hassan Journal: Int Urol Nephrol Date: 2015-04-22 Impact factor: 2.370
Authors: René P Schellart; Sandra E Zwolsman; Jean-Philippe Lucot; Dirk J M K de Ridder; Marcel G W Dijkgraaf; Jan-Paul W R Roovers Journal: Int Urogynecol J Date: 2017-06-02 Impact factor: 2.894
Authors: Annetta M Madsen; Sherif A El-Nashar; Joshua L Woelk; Christopher J Klingele; John B Gebhart; Emanuel C Trabuco Journal: Int Urogynecol J Date: 2013-09-17 Impact factor: 2.894
Authors: René P Schellart; Katrien Oude Rengerink; Frank Van der Aa; Jean-Philippe Lucot; Bart Kimpe; Marcel G W Dijkgraaf; Jan-Paul W R Roovers Journal: Int Urogynecol J Date: 2015-12-15 Impact factor: 2.894